These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9035852)

  • 1. [The efficacy of using Zanocin in infectious diseases].
    Rudenko AA; Shapiro AV; Kononenko VV; Muravskaia LV; Diadiun ST; Okruzhnov NV; Sidorova ZhP
    Lik Sprava; 1996; (3-4):140-3. PubMed ID: 9035852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy of drug-resistant tuberculosis with inclusion of ofloxacin (zanocin)].
    Padeĭskaia EN
    Antibiot Khimioter; 2001; 46(8):9-18. PubMed ID: 11871320
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson R; Cavalcanti R; Brunton JL; Bast DJ; de Azavedo JC; Kibsey P; Fleming C; Low DE
    N Engl J Med; 2002 Mar; 346(10):747-50. PubMed ID: 11882730
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical efficacy of the new quinolones in lower respiratory infections.
    Davies BI; Maesen FP
    Chemioterapia; 1987 Jun; 6(2 Suppl):447-8. PubMed ID: 3509469
    [No Abstract]   [Full Text] [Related]  

  • 6. [A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
    Saenko VF; Viktorov AP; Golopykho LI; Nichitaĭlo ME; Gorshevikova EV
    Klin Khir; 1995; (9-10):18-9. PubMed ID: 8697205
    [No Abstract]   [Full Text] [Related]  

  • 7. Levofloxacin-resistant pneumococcus.
    Klugman KP
    Clin Infect Dis; 2000 Aug; 31(2):626-7. PubMed ID: 10987743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of ofloxacin in the treatment of suppurative-inflammatory complications in surgery].
    Bogomolova NS; Bol'shakov LV; Vinogradova LN; Sorokina VI; Oreshkina TD; Tret'iakova ES
    Anesteziol Reanimatol; 1997; (3):18-20. PubMed ID: 9289979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2016 JAID/JSC guidelines for clinical management of infectious disease-Odontogenic infections.
    ; ;
    J Infect Chemother; 2018 May; 24(5):320-324. PubMed ID: 29503229
    [No Abstract]   [Full Text] [Related]  

  • 10. Levofloxacin, a new quinolone antibacterial agent. An introductory overview.
    Hayakawa I; Furuhama K; Takayama S; Osada Y
    Arzneimittelforschung; 1992 Mar; 43(3A):363-4. PubMed ID: 1622431
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
    Fogarty C; Goldschmidt R; Bush K
    Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofloxacin as the standard 4-quinolone in sensitivity tests.
    Amyes SG; Paton RH; Miles RS; Hood J
    J Antimicrob Chemother; 1992 Jul; 30(1):101-2. PubMed ID: 1429327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ofloxacin in comprehensive treatment of infections in burn patients].
    Krutikov MG; Alekseev AA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1996; 41(9):77-80. PubMed ID: 9005793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rapid development of fluoroquinolone resistance in M. tuberculosis.
    Ginsburg AS; Woolwine SC; Hooper N; Benjamin WH; Bishai WR; Dorman SE; Sterling TR
    N Engl J Med; 2003 Nov; 349(20):1977-8. PubMed ID: 14614180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Levofloxacin].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(4):220-5. PubMed ID: 10420933
    [No Abstract]   [Full Text] [Related]  

  • 17. The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s.
    Armstrong D; Neu H; Peterson LR; Tomasz A
    Microb Drug Resist; 1995; 1(1):1-4. PubMed ID: 9156378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in the use of ofloxacin in the prevention and treatment of wound infection in burns].
    Alekseev AA; Iakovlev VP; Krutikov MG; Kashin ID; Dutikov VN; Elagina LV; Izotova GN
    Klin Med (Mosk); 1995; 73(6):46-51. PubMed ID: 8691783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia.
    Lin Y; Su W; Xu Z; Bai Y
    Chin Med J (Engl); 2001 Feb; 114(2):212-3. PubMed ID: 11780213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.